Business Wire

DE-CSC

7.3.2019 15:02:12 CET | Business Wire | Press release

Share
CSC Alerts Companies to Increased DNS Hijacking

CSC joins the U.S. Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency, the UK National Cyber Security Centre, and other leading security organizations—including Cisco® Talos, FireEye® , and Akamai—in alerting corporations and the public to the recent widespread, state-sponsored domain name system (DNS) hijacking attacks. The targets of these recent attacks include government, corporate, telecommunication, and infrastructure entities resulting in website and email redirection to collect sensitive information. We urge companies to stay vigilant and employ security protocols to reduce exposure.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190307005082/en/

DNS attacks can lead to criminals redirecting web traffic away from a legitimate site to a rogue site, putting customers and companies at great risk,” says Mark Flegg, product director for Security Services at CSC. “The recent attacks are complex and vicious, exploiting weaknesses in DNS infrastructure that many companies set up once, then neglect. We strongly advise clients to use the tools and recommendations available to get their digital infrastructure secure.”

In response to DNS hijacking risk and other cyber crime, CSC introduced CSC Security CenterSM in 2018. It’s an online interface powered by advanced proprietary algorithms designed to expose security blind spots across domain names, DNS, and digital certificates that make vital online brand assets susceptible to DNS hijacking, phishing, and distributed denial of service attacks.

“Domain and DNS hijacking are not new security threats, which is why we developed CSC Security Center and are encouraged that hundreds of the world's largest companies are using it to help protect these critical online elements that enable them to operate,” says CSC Digital Brand Services General Manager Mark Calandra. “The sophistication and impact of the recent wave of attacks serves as a wakeup call that effectively managing domain names, DNS, and digital certificates needs to be a critical component for enhancing the security posture of any company with an online presence.”

CSC Security Center proactively identifies business-critical domains, and monitors them continually to ensure they’re protected. This includes checking for registry- and registrar-level locks that prevent unauthorized changes, reviewing user permissions, and verifying that security-focused, enterprise-class DNS hosting and digital certificates are implemented.

“The new CSC Security Center was a welcome surprise,” says Altan Changezi, lead infrastructure architect at Manulife. “It very quickly allows me to see—at a high level—our overall digital asset configuration at CSC. This includes the status of our most vital domains, as well as the number of users with privileged access to our CSC-managed web portals. The tool allows us to make proactive decisions to take control of our assets, as well as secure our accounts.”

The constant identification and monitoring of vital domains alerting companies to security blind spots allows them to take quick action to reduce real-world online threats to their web presence, customer data, and business-critical functions.

“CSC Security Center has shown us where we needed to consolidate providers, update our permissions and security protocols to be consistent with the importance of the website, and much more,” says John Howell, IT operations manager at Football Federation Australia. “The interface is user friendly and alerts us to where we need to keep watch or increase security. I’ve never seen anything like it before, and knowing I can chat with my CSC rep about any of the security blind spots that are revealed—and get protected right away—gives us peace of mind that our data and customers are protected.”

CSC Security Center helps clients reduce exposure to cyber crime by providing them a single view into all risk areas.

About CSC

CSC helps businesses thrive online. We help effectively manage, promote, and secure our clients’ valuable brand assets against the threats of the online world. Leading companies around the world choose us to be their trusted partner, including more than 65% of the Interbrand® 100 Best Global Brands. Leveraging state-of-the-art technology, Digital Brand Services delivers outstanding outcomes through our unique account management structure. With our expert, dedicated team, you’ll have a daily point of contact to ensure your brand has the strength it needs to succeed in the 21st century. We help consolidate and secure, monitor and enforce, then optimize and promote your brands to maximize your digital presence, secure your digital intellectual property, and reduce costs. CSC is the world’s leading provider of digital brand services to companies around the globe. Headquartered in Wilmington, Delaware, CSC also operates from offices throughout the U.S., Canada, Europe, and the Asia-Pacific region. Learn more at cscdigitalbrand.services .

Contact:

Laura Crozier Public Relations Manager, USA (302) 693-5401 x. 65526 laura.crozier@cscglobal.com

Marie Le Maitre Global Marketing Manager, EMEA +44 (0)20 75132324 marie.lemaitre@cscglobal.com

Letitia Thian Marketing Manager, APAC +65 6709 0104 x. 80104 letitia.thian@cscglobal.com

CSC ® News Room

Link:

ClickThru

Social Media:

https://www.facebook.com/CSCSince1899/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye